The Effectiveness of Dimethyl Fumarate Monotherapy in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis

BACKGROUND: Dimethyl fumarate (BG-12, Tecfidera®) is a new oral drug approved by FDA and EMA in March 2013 for relapsing – remitting multiple sclerosis (RRMS). The drug was much anticipated because of its possible superiority over currently available medications: fingolimod and teriflunomide as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawalec, Paweł, Mikrut, Alicja, Wiśniewska, Natalia, Pilc, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023455/
https://www.ncbi.nlm.nih.gov/pubmed/24851089
http://dx.doi.org/10.2174/1570159X12666140115214801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023455/
https://www.ncbi.nlm.nih.gov/pubmed/24851089
http://dx.doi.org/10.2174/1570159X12666140115214801

Ejemplares similares